Research Update: Cleaning & Disinfecting PPE for Reuse

A webinar with EPA Researchers John Archer and Anne Mikelonis
Environmental Protection Agency - Center for Environmental Solutions and Emergency Response (CESER)

Research Alert

The COVID-19 pandemic has caused an unprecedented disruption in supply chains across multiple sectors including the shortage of critical personal protective equipment (PPE). In addition to hand washing and social distancing, various PPE items are used to prevent contact with droplets and aerosols, reducing potential exposure to SARS-CoV-2, the virus that causes COVID-19.

Effective, low-technology, disinfection methods for certain specialized-use items, such as filtering-facepiece respirators, medical-use masks, face shields, and body coveralls, as well as non-specialized items, like procedural masks, face coverings, clothing, and shoes, are limited outside of healthcare setting applications.

EPA researchers are evaluating the effectiveness of selected cleaning and disinfection technologies and commercial off-the-shelf products for these PPE items for potential reuse. The evaluation includes disinfection efficacy tests coupled with wear cycles and integrity tests on the PPE materials after exposure to disinfectants to reflect real-world use of such items and to help determine whether it impacts the wearer.

During this webinar, researchers will discuss their evaluation of cleaning protocols and disinfection techniques that can be used for the disinfection of disposble and reusable PPE contaminated with viruses. This information will help responders and the general public understand what type of low-tech cleaning and disinfection is most effective without the loss of integrity of the PPE. Learn more about the webinar and to register, please visit: https://www.epa.gov/emergency-response-research/webinar-series

Learn more about EPA's research on Covid-19: https://www.epa.gov/covid19-research

EPA Researchers:

John Archer

Anne Mikelonis

 




Filters close

Showing results

110 of 5639
access_time Embargo lifts in 2 days
Embargo will expire: 20-May-2021 10:00 AM EDT Released to reporters: 14-May-2021 2:40 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 20-May-2021 10:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 14-May-2021 11:25 AM EDT
Access to overdose-reversing drugs declined during pandemic, researchers find
Beth Israel Lahey Health

In a new study, clinician-researchers at Beth Israel Deaconess Medical Center (BIDMC) analyzed naloxone prescription trends during the COVID-19 pandemic in the United States and compared them to trends in opioid prescriptions and to overall prescriptions.

Released: 14-May-2021 11:00 AM EDT
No Excuses: Stop Procrastinating on These Key Health Checks
Michigan Medicine - University of Michigan

A quick guide to the most-valuable preventive care that adults need to get scheduled, to catch up on what they may have missed during the height of the pandemic, and to address issues that the pandemic might have worsened.

Released: 13-May-2021 7:05 PM EDT
FLCCC Statement on the Irregular Actions of Public Health Agencies & the Disinformation Campaign Against Ivermectin
Front Line COVID-19 Critical Care Alliance (FLCCC Alliance)

FLCCC Alliance calls for whistleblower to step forward from within WHO, the FDA, the NIH, Merck, or Unitaid to counter this misrepresentation

Newswise: shutterstock_1724336896.jpg
Released: 13-May-2021 12:55 PM EDT
Kreuter receives $1.9 million in grants to increase vaccinations in St. Louis
Washington University in St. Louis

Matthew Kreuter, the Kahn Family Professor of Public Health at the Brown School, has received $1.9 million in grants to help increase COVID-19 vaccinations among Blacks in St. Louis City and County.

Released: 13-May-2021 11:35 AM EDT
COVID-19 mRNA Vaccines are Immunogenic in Pregnant and Lactating Women, Including Against Viral Variants
Beth Israel Deaconess Medical Center

In a new study from Beth Israel Deaconess Medical Center researchers evaluated the immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women who received either the Pfizer or Moderna COVID-19 vaccines. They found that both vaccines triggered immune responses in pregnant and lactating women.

Released: 13-May-2021 10:30 AM EDT
Pandemic stigma: Foreigners, doctors wrongly targeted for COVID-19 spread in India
Monash University

The Indian public blamed foreigners, minority groups and doctors for the rapid spread of COVID-19 across the country during the first wave, due to misinformation, rumour and long-held discriminatory beliefs, according to an international study led by Monash University.

Released: 13-May-2021 9:15 AM EDT
28 Community Programs Receive Grants Through Penn Medicine CAREs Program
Perelman School of Medicine at the University of Pennsylvania

Penn Medicine CAREs awarded grants to 28 projects, many of which aim to fill vast needs in the community created by the COVID-19 pandemic, while others seek to improve diversity, equity, and inclusion.


Showing results

110 of 5639

close
3.17858